Sites / South Florida Clinical Research Institute
Is this you?

Request access for South Florida Clinical Research Institute with your @sfcri.net work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

South Florida Clinical Research Institute

Unclaimed profile

Independent Site Network · Margate, FL · ~1-2 sites

Intera lens
ICP 3Lift (cardio sample) 0.57Recruit soph 0.43
Quality Scorecard (1–100)
Overall81Recruit65Ops83Sponsor93Ther86

Performance (observed)

Historical trials
479
Completed
276
Terminated/Withdrawn
56
Completion rate
83%
Active now
138
Phase 2
125
Phase 3
286
Realized enrollment
370,740
First study year
1996
Years active
30
Match confidence
high
Enrollment velocity (inf)
12,358

Therapeutic

Areas
Diabetes (T1&T2), Cardiovascular, Endometriosis, Hormone Therapy, HPV, Menopause, Osteoporosis, Uterine Fibroids, Vaginal Atrophy, Autoimmune, Cardiology, Endocrinology, Neurology, Pain Mgmt, Pediatrics, Pulmonology, Vaccines, Women's Health
Specialties
Multi-specialty; 35+ years combined staff experience
Breadth (conditions)
650
Languages
English/Spanish
States
FL

Recruitment (web observed)

Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Y (active blog on recruitment/site management)
Capability notes
Active recruitment for diverse therapeutic areas

Relationships

Sponsors
Pfizer; AbbVie; Hoffmann-La Roche; Eli Lilly and Company; National Cancer Institute (NCI); Gilead Sciences
CROs
Allucent; Clinipace Worldwide; ICON Clinical Research; IQVIA Pty Ltd; MacroGenics; PPD Development, LP
Owner / parent
Private; Estimated $600K-$1M revenue; 2 employees
Acquisitions
N

Capacity & people

Investigators
Coordinators
CEO
Unknown
VP Clinical Ops
LeRoy Reynolds, RPh (Clinical Operations Officer; 29+ years pharma experience, former Eli Lilly)
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
information@sfcri.net

Tech & DCT

eSource
Yes
Builds tech
Unknown
Tech stack
Not disclosed
Recruiting visible
Y

Notes

Multi-specialty clinical research firm with strong therapeutic area diversity (vaccines, cardiology, women's health). 35+ years combined team experience. However, very small operational scale (2 employees, <$1M revenue), limited to Florida. Strong recruitment focus but no visible tech innovation or AI. Marginal Intera fit—diverse therapeutic areas good, but micro-scale and no tech/automation signals. [Validated: 4 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 1.00Liftability 0.57Overall81

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.